Therapeutic Neovascularization Using Cord Blood–Derived Endothelial Progenitor Cells for Diabetic Neuropathy

(Downloading may take up to 30 seconds. If the slide opens in your browser, select File -> Save As to save it.)

Click on image to view larger version.

FIG. 1.
FIG. 1.

Differentiation and identification of EPCs from human umbilical cord blood MNCs in vitro. Differentiation of EPCs: when cord blood MNCs were cultured on fibronectin, attached cells (A) and cell clusters (B) sprouted. C: After 7 days of culture, the cells showed enhanced differentiation, such as cord-like structure. D: Cells showed a cobblestone pattern when they matured. E: Identification of EPCs. When cells were isolated from culture plates on basement membrane matrix gel, tube formation was identified in the matrigel. F: More than 95% of the isolated cells showed the uptake of DiI-acetylated LDL. FACS analyses of isolated cells were conducted after 7 days of culture. Cells were labeled with fluorescent antibodies to CD34 (G) or CD45 (H).

This Article

  1. Diabetes vol. 54 no. 6 1823-1828